Advertisement
Women with advanced

AACR: Atezolizumab Aids Some With Triple-Negative Breast CA

0
A minority of women with triple-negative tumors responded to atezolizumab, but they responded well
Mylan

Mylan Issues Voluntary Recall of Some EpiPen Auto-Injectors

0
Rare cases of 'failure to activate' spurred the action, company says
For patients with pretreated advanced non-small-cell lung cancer

AACR: Five-Year Survival 16 Percent With Nivolumab in NSCLC

0
Of the 16 patients who survived at least five years, nine were male, 12 were current smokers at baseline
Patients with isolated superficial vein thrombosis have a similar overall risk of recurrence as those with proximal deep vein thrombosis

Overall Risk of VTE Recurrence Similar for iSVT, Proximal DVT

0
Isolated superficial vein thrombosis tied to increased risk of iSVT recurrence, lower risk of deep-VTE events
Maintenance therapy with cediranib for women with relapsed ovarian cancer is not detrimental to quality of life

Cediranib Tx in Relapsed Ovarian CA Doesn’t Lower Quality of Life

0
Findings among women on maintenance therapy for relapsed ovarian cancer
Children with tympanostomy tube placement exposed to quinolone ear drops may have an increased risk of perforations requiring tympanoplasty

Quinolone Ear Drops Increase Perforation Risk With Ear Tubes

0
Risk of perforation may be further exaggerated by ear drops with quinolone plus corticosteroids
For postmenopausal women undergoing surgical treatment for pelvic organ prolapse

Estriol Gel Aids Vaginal Health Pre, Post Genital Prolapse Sx

0
Significant improvement in vaginal health before and after surgery for pelvic organ prolapse
Insurance products offered by hospitals and health systems

Vertical Integration Insurance Products of Higher Quality

0
Slight increase in percentage of insurance products offered by hospitals, health systems from 2011-2015
For patients with dementia

Proton Pump Inhibitor Use Ups Pneumonia Risk in Dementia

0
Independent risk factors for pneumonia include age, male gender, underlying cerebrovascular disease
Hepatitis B and C could be eliminated as serious public health problems in the United States by 2030

Hep B, C Could Be Eliminated As Public Health Threats by 2030

0
Tools exist to prevent hepatitis B and C mortality, including vaccination and treatment